You are here

Vaccine reduces cervical-cancer virus' prevalence in teenage girls by almost 65%

Latest study may energise a tumultuous struggle in America to encourage HPV vaccination
Tuesday, February 23, 2016 - 05:50

New York

A VACCINE introduced a decade ago to combat the sexually transmitted virus that causes cervical cancer has already reduced the virus' prevalence in teenage girls by almost two-thirds, federal researchers said on Monday.

Even for women in their early 20s, a group with lower

Market voices on:

Pair your daily business read with the perfect cup of espresso.

Subscribe to The Business Times today to receive your very own Nespresso Inissia coffee machine worth $188.

Find out more at

Powered by GET.comGetCom